LGI LIMITED — Director's Dealing 2024

Mar 3, 2024

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity LGI Limited ABN 49 138 085 551

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Jessica Catherine North
Date of last notice	7 September 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	1. 29 Feb 2024 (On-market Share Sale) 2. 1 Mar 2024 (Escrow Release);and 3. 4 Mar 2024 (Exercise of Employee Options).

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change Dr Jessica North Dr Jessica Catherine North	1,299,200 Fully Paid Ordinary Shares (Shares)as follows: • 866,134 unrestricted Shares. • 433,066 Shares escrowed until after the release of Half Year 2024 results. 300,000 Employee Optionsexercisable at $0.70 per Share, expiring on 31 January 2025, of which 100,000 Options were restricted until the release of the HY24 results. 100,000 Employee Optionsexercisable at $0.925 per Share, expiring on 31 January 2025 as follows, of which 33,333 Options were restricted until the release of the HY24 results. 200 Fully Paid Ordinary Shares (Shares)
Class	Shares and Employee Options
Number acquired	Escrow Release 433,066 Shares and 133,333 Employee Options were released from escrow. Exercise of Employee Options 400,000 Shares from exercise of 400,000 Employee Options

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Number disposed	On-market Share Sale 150,000 Fully Paid Ordinary Shares (Shares) Escrow Release 433,066 Shares and 133,333 Employee Options were released from escrow. Exercise of Employee Options 400,000 Employee Options exercised resulting in the issue of 400,000 Shares.
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	On-market Share Sale 150,000 Shares at $2.20 per Share Escrow Release 433,066 Shares and 133,333 Employee Options were released from escrow (nil consideration). Exercise of Employee Options 400,000 Employee Options were exercised, resulting in 300,000 Shares at $0.70 per Share and 100,00 Shares at $0.925 per Share.
No. of securities held after change Dr Jessica North Dr Jessica Catherine North	1,549,200 Fully Paid Ordinary Shares 200 Fully Paid Ordinary Shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back	On-market Share Sale to fund the exercise of Employee Options; and the release of voluntary escrow described in section 6.2 of the Prospectus dated 17 August 2022.

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 322] intentionally omitted <==

----- Start of picture text -----

Detail of contract
N/A
Nature of interest
N/A
Name of registered holder
(if issued securities) N/A
Date of change
N/A
No. and class of securities to which
interest related prior to change
N/A
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
N/A
Interest disposed
N/A
Value/Consideration
Note: If consideration is non-cash, provide details N/A
and an estimated valuation
Interest after change
N/A
----- End of picture text -----

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	NO
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011